In addition, there was a significant association of shorter disease-specific survival in patients with tumours that express high SK1 or S1P4 (29 patients) compared with those that express low SK1 and S1P4 levels (108 patients; P=0.001; Figure 3C). This evidence concerns the gene S1PR4 and neoplasm.